Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer
Conditions: Head and Neck Cancer; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck Interventions: Drug: Xevinapant; Drug: Carboplatin; Drug: Paclitaxel; Radiation: Radiation Therapy Sponsors: University of Chicago; EMD Serono Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Head and Neck Cancer | Radiation Therapy | Research | Skin Cancer | Squamous Cell Carcinoma | Study